We are live on ! Find out more
ACM

AlphaCrest Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
-7.05%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
10 Year Est. Return
AUM
$1.64B
AUM Growth
-$431M
Cap. Flow
-$291M
Cap. Flow %
-17.73%
Top 10 Hldgs %
4.35%
Holding
1,432
New
196
Increased
495
Reduced
565
Closed
176

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$8.3M
2
USB icon
US Bancorp
USB
+$8.26M
3
SYY icon
Sysco
SYY
+$5.67M
4
O icon
Realty Income
O
+$5.32M
5
KO icon
Coca-Cola
KO
+$5.28M

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$17.9M
2
EA icon
Electronic Arts
EA
+$14M
3
BMY icon
Bristol-Myers Squibb
BMY
+$11M
4
JPM icon
JPMorgan Chase
JPM
+$10.9M
5
AMGN icon
Amgen
AMGN
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 17.02%
2 Financials 16.14%
3 Healthcare 13.06%
4 Industrials 12.93%
5 Consumer Discretionary 11.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAC icon
1251
Macerich
MAC
$7.39B
$134K 0.01%
16,822
-79,945
-83% -$776K
FTI icon
1252
TechnipFMC
FTI
$29.9B
$130K 0.01%
15,361
-3,853
-20% -$30.4K
NMRK icon
1253
Newmark Group
NMRK
$2.82B
$95K 0.01%
11,806
-358,820
-97% -$3.7M
FTCH
1254
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$82K 0.01%
+10,969
New +$97.4K
SABR icon
1255
Sabre
SABR
$704M
$80K ﹤0.01%
15,518
-4,082
-21% -$27.2K
COTY icon
1256
Coty
COTY
$2.39B
$64K ﹤0.01%
10,048
-22,366
-69% -$169K
ABCB icon
1257
Ameris Bancorp
ABCB
$5.8B
-29,980
Closed -$1.21M
ACLS icon
1258
Axcelis
ACLS
$3.96B
-14,271
Closed -$783K
ADPT icon
1259
Adaptive Biotechnologies
ADPT
$3.58B
-66,066
Closed -$534K
ADT icon
1260
ADT
ADT
$5.24B
-242,528
Closed -$1.49M
AHCO icon
1261
AdaptHealth
AHCO
$1.5B
-31,885
Closed -$575K
AIV
1262
Aimco
AIV
$380M
-36,919
Closed -$236K
ANF icon
1263
Abercrombie & Fitch
ANF
$4.41B
-29,300
Closed -$496K
ARVN icon
1264
Arvinas
ARVN
$536M
-7,603
Closed -$320K
ARWR icon
1265
Arrowhead Research
ARWR
$12.2B
-19,225
Closed -$677K
CVSA
1266
Covista Inc
CVSA
$4.08B
-24,230
Closed -$872K
ATI icon
1267
ATI
ATI
$26.2B
-13,855
Closed -$315K
BALY icon
1268
Bally's
BALY
$687M
-33,397
Closed -$661K
BB icon
1269
BlackBerry
BB
$4.96B
-101,800
Closed -$549K
BBWI icon
1270
Bath & Body Works
BBWI
$4.13B
-15,956
Closed -$430K
BEPC icon
1271
Brookfield Renewable
BEPC
$5.94B
-10,989
Closed -$391K
BHC icon
1272
Bausch Health
BHC
$1.68B
-108,657
Closed -$908K
BIIB icon
1273
Biogen
BIIB
$29.7B
-3,312
Closed -$675K
BMBL icon
1274
Bumble
BMBL
$383M
-44,100
Closed -$1.24M
CALX icon
1275
Calix
CALX
$2.31B
-6,887
Closed -$235K

Similar funds

AlphaCrest Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, AlphaCrest Capital Management held 1,432 positions worth $1.64B, down 21% from $2.07B the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

AlphaCrest Capital Management withdrew a net $291M in Q3 2022, closing 176 positions and reducing 565 holdings. Its most notable exit was Stryker, an estimated $7.96M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, AlphaCrest Capital Management opened a new position in AT&T worth $3.27M.

  • AlphaCrest Capital Management's largest Q3 2022 buy was AT&T: 212,810 shares worth $3.27M.
  • AlphaCrest Capital Management added most to American Tower in Q3 2022, an estimated $8.3M increase.
  • AlphaCrest Capital Management's biggest Q3 2022 reduction was Target, cutting an estimated $17.9M.
  • AlphaCrest Capital Management fully exited Stryker in Q3 2022, selling an estimated $7.96M.
  • AlphaCrest Capital Management's ten largest holdings make up 4.4% of its $1.64B portfolio in Q3 2022.
  • AlphaCrest Capital Management opened 196 new positions and closed 176 in Q3 2022.
  • AlphaCrest Capital Management's portfolio value fell 21% quarter-over-quarter to $1.64B.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.